Open access
Open access
Powered by Google Translator Translator

Antibiotic Stewardship

Legionnaires’ Disease: Update on diagnosis and treatment.

10 May, 2022 | 11:06h | UTC

Legionnaires’ Disease: Update on Diagnosis and Treatment – Infectious Diseases and Therapy

 

Commentary on Twitter

Under a http://creativecommons.org/licenses/by-nc/4.0/ license

 

Recommendations for change in infection prevention programs and practice.

10 May, 2022 | 10:56h | UTC

Recommendations for Change in Infection Prevention Programs and Practice – American Journal of Infection Control

 

WHO launches first ever global report on infection prevention and control.

9 May, 2022 | 02:19h | UTC

News Release: WHO launches first ever global report on infection prevention and control – World Health Organization

Executive Summary: Global report on infection prevention and control – World Health Organization

 

Commentary on Twitter

 

Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

9 May, 2022 | 01:32h | UTC

Clinical challenges treating Stenotrophomonas maltophilia infections: an update – JAC-Antimicrobial Resistance

Related:

Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach – Open Forum Infectious Diseases

Risk Factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: A Systematic Review and Meta-Analysis – Frontiers in Medicine

Trimethoprim-Sulfamethoxazole versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 U.S. Hospitals – Open Forum Infectious Diseases

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections – Clinical Infectious Diseases

 

Diagnostic stewardship tied to fewer blood cultures, antibiotics in sick kids.

9 May, 2022 | 01:23h | UTC

Commentary: Diagnostic stewardship tied to fewer blood cultures, antibiotics in sick kids – CIDRAP

Original Study: Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative – JAMA Peditrics

News Release: Hospitals can reduce antibiotic overuse by avoiding unnecessary blood draws in critically ill children, study shows – Johns Hopkins University School of Medicine

 

Commentary on Twitter

 

Podcast: Appendicitis Pearls.

9 May, 2022 | 01:15h | UTC

#49: Appendicitis – Tips and Tricks For When It’s the Appendix – The Cribsiders

 

M-A: Interventions for high-burden infectious diseases in children and adolescents.

9 May, 2022 | 01:12h | UTC

Interventions for High-Burden Infectious Diseases in Children and Adolescents: A Meta-analysis – Pediatrics

 

Review: Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach.

6 May, 2022 | 10:31h | UTC

Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach – Open Forum Infectious Diseases

 

Review: Non-invasive testing and surrogate markers in invasive fungal diseases.

6 May, 2022 | 10:29h | UTC

Non-invasive Testing and Surrogate Markers in Invasive Fungal Diseases – Open Forum Infectious Diseases

 

Retrospective cohort study: Treatment outcome with penicillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bacteremia.

5 May, 2022 | 09:39h | UTC

Treatment outcome with penicillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bacteraemia – A retrospective cohort study – International Journal of Antimicrobial Agents

 

Commentary on Twitter

 

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.

4 May, 2022 | 10:36h | UTC

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection – Nature Communications

 

Commentary on Twitter (thread – click for more)

https://twitter.com/JessicaLittleMD/status/1521513877242101762

 

M-A: Risk factors for contracting invasive meningococcal disease and related mortality.

3 May, 2022 | 10:29h | UTC

Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis – International Journal of Infectious Diseases

 

RCT: Extended vs. standard antibiotic course duration in children below 5 years of age hospitalized with community-acquired pneumonia in high-risk settings.

29 Apr, 2022 | 11:16h | UTC

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial – The Pediatric Infectious Disease Journal

Related:

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial – JAMA Pediatrics

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians – Annals of Internal Medicine

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA

Treatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics

Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial – JAMA

Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial – Clinical Infectious Diseases

Efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults: A systematic review and meta-analysis – Antimicrobial Agents and Chemotherapy

 

Commentary on Twitter

 

Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them.

29 Apr, 2022 | 10:51h | UTC

Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them – Antimicrobial Stewardship & Healthcare Epidemiology

 

Commentary on Twitter

Under a http://creativecommons.org/licenses/by/4.0/ license

 

M-A: Risk factors for acquired Stenotrophomonas maltophilia pneumonia in intensive care unit.

28 Apr, 2022 | 08:01h | UTC

Risk Factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: A Systematic Review and Meta-Analysis – Frontiers in Medicine

 

Review: Use of antimicrobials for bloodstream infections in the intensive care unit.

27 Apr, 2022 | 01:34h | UTC

Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review – Antibiotics

 

Consensus for the treatment of tinea pedis.

26 Apr, 2022 | 08:02h | UTC

Consensus for the Treatment of Tinea Pedis: A Systematic Review of Randomised Controlled Trials – Journal of Fungi

 

Studies highlight meningitis vaccine’s potential against gonorrhea.

20 Apr, 2022 | 10:06h | UTC

Commentary: Studies highlight meningitis vaccine’s potential against gonorrhea – CIDRAP

News Release: Threat of untreatable gonorrhoea could be tackled using an existing meningitis vaccine – The Lancet

Study 1: Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study – The Lancet Infectious Diseases (link to abstract – $ for full-text)

Study 2: Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study – The Lancet Infectious Diseases (link to abstract – $ for full-text)

Study 3: Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis – The Lancet Infectious Diseases

 

Expert Guidance: Strategies to prevent central line-associated bloodstream infections in acute-care hospitals.

20 Apr, 2022 | 10:13h | UTC

Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update – Infection Control & Hospital Epidemiology

 

Commentary on Twitter

Article under a http://creativecommons.org/licenses/by/4.0/ license

 

AAOS Guideline: Prevention of surgical site infections after major extremity trauma.

19 Apr, 2022 | 02:35h | UTC

Prevention of Surgical Site Infections After Major Extremity Trauma: Evidence-Based Clinical Practice Guideline – American Academy of Orthopaedic Surgeons

Evidence Review: Prevention of Surgical Site Infection After Extremity Trauma (2022)

 

RCT: A 12-months oral itraconazole regimen is superior to 6-months of treatment to prevent relapses of chronic pulmonary aspergillosis.

18 Apr, 2022 | 10:36h | UTC

Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India – The Lancet Infectious Diseases (link to abstract – $ for full-text)

 

Diarrhea during critical illness: a multicenter cohort study.

18 Apr, 2022 | 10:20h | UTC

Diarrhea during critical illness: a multicenter cohort study – Intensive Care Medicine

 

Commentary on Twitter

 

Guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing.

18 Apr, 2022 | 10:26h | UTC

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring – Pharmaceutics

Related Guideline:

Guideline: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists – Clinical Infectious Diseases

 

Commentary on Twitter

https://twitter.com/IDPharmacometrx/status/1514219239732912131

 

Prospective validation of a rapid host gene expression test to discriminate bacterial from viral respiratory infection.

18 Apr, 2022 | 09:58h | UTC

Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection – JAMA Network Open

 

Commentary on Twitter

 

Risk for asymptomatic household transmission of Clostridioides difficile infection associated with recently hospitalized family members.

18 Apr, 2022 | 09:41h | UTC

Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members – Emerging Infectious Diseases

Commentary: Recently Discharged Patients Pose Risk for Spreading C. Difficile Infection – HealthDay

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.